Body And Mind Inc Stock Price, News & Analysis

Body and Mind Inc. (BMMJ) announced a significant expansion of its wholesale operations in Ohio and Arkansas. In Ohio, the company is launching new extracted products and preparing to introduce popular edibles. In Arkansas, the company has successfully ramped up its cultivation operations, with proprietary strains receiving market acclaim. The firm has initiated sales through its dispensary and is collaborating with local extractors. Body and Mind aims to enhance shareholder value through operational improvements and by leveraging its Nevada product portfolio in these new markets.

Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) has rebranded its San Diego dispensary from ShowGrow to Body and Mind to strengthen brand alignment. The company plans to expand operations in Ohio, having received kitchen certification for edibles production. Additionally, it is preparing for a busy 4/20 week in Nevada, collaborating with local dispensaries and launching products. Body and Mind has also completed pheno-hunting in Arkansas and is ramping up for a busy period in Michigan, while actively participating in cannabis legalization initiatives.

Body and Mind Inc. (BMMJ) reported a 27% year-over-year revenue growth for Q2 FY2022, totaling $8.05 million. Sequential growth was 6% compared to Q1 FY2022. The company achieved a gross profit of $3.02 million, up 10% year-over-year. However, it recorded a net loss of $2.72 million and a net operating loss of $0.97 million. Cash reserves stood at $4.62 million with a working capital surplus of $4.07 million. BaM continues to expand its operations across several states, focusing on cannabis production and retail.

Body and Mind Inc. (BMMJ) announces plans to release its fiscal Q2 2022 results for the period ending January 31, 2022, on March 17, 2022, after market close. A conference call to discuss these results is scheduled for March 18, 2022, at 2 p.m. ET. BaM operates across multiple U.S. states, focusing on medical and recreational cannabis products. The company aims to enhance shareholder value through operational efficiencies, licensing, and potential mergers. Their Nevada subsidiary holds significant cultivation licenses and has received multiple awards for its cannabis strains.

Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) has opened its first Body and Mind branded dispensary in Muskegon, Michigan, marking a significant expansion into this high-growth cannabis market. The dispensary, serving both medical and recreational customers, coincides with a 66% year-over-year sales increase in Michigan's cannabis industry. In addition, the company is developing a 57,000 sq. ft. cultivation facility. The rebranding of its Long Beach dispensary is complete, and operations have commenced at a recently acquired Seaside dispensary. The company aims to enhance community relationships while focusing on operational efficiencies.

Body and Mind Inc. (BMMJ) reported a strong Q1 FY2022 with revenues of $7.57 million, marking a 43% year-over-year increase. Gross profit surged 94% to $3.49 million. The company achieved an operational net profit of $0.32 million, although there was a net loss of $0.68 million. Cash reserves stood at $7.43 million. Ongoing operational developments include new acquisitions and expansions in several states. An earnings call is scheduled for December 17.

Body and Mind Inc. (BMMJ) has signed definitive agreements to acquire 100% of Canopy Monterey Bay, which operates a retail dispensary in Seaside, California. The total consideration for the acquisition includes US$4.8 million, primarily in cash, and a promissory note. Body and Mind plans to consolidate revenues from this acquisition pending local and state approvals. Additionally, the company is expanding its Michigan dispensary and cultivation operations in Arkansas. A loan agreement has been amended for better capital efficiency, and stock options have been granted to executives.

Body and Mind Inc. (CSE: BAMM, OTCQB: BMMJ) announced record annual consolidated revenue of $26.90 million for FY2021, marking a significant 332% increase compared to FY2020's $6.23 million. The company reported a net loss of $1.98 million, an improvement from the prior year's loss of $4.60 million, with a gross profit margin of 45%. Notably, Q4 revenue was $8.14 million, up 14% from Q3. Despite losses, adjusted EBITDA improved to $3.96 million. Key operational milestones were achieved across several states, indicating ongoing growth and expansion efforts.